Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
Pain in the arm was reported as worsened; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of pain in arm in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included simvastatin, metoprolol, lisinopril and metformin. On 14-AUG-2025, the patient received the 1st dose of Shingrix (left deltoid). On 14-AUG-2025, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: Pain in the arm was reported as worsened). The outcome of the pain in arm was not resolved. The reporter considered the pain in arm to be related to Shingrix. The company considered the pain in arm to be related to Shingrix. Additional Information: GSK Receipt Date: 15-AUG-2025 The patient received a dose of Shingrix vaccine and experienced pain in the arm. It was reported as worsened.
SIMVASTATIN; METOPROLOL; LISINOPRIL; METFORMIN